Literature DB >> 15641697

Relationship between the expression of connexin43 and bystander effect of suicide gene therapy in ovarian cancer.

Ali Zhang1, Quansheng Wang, Zhiqiang Han, Sufang Wu, Gang Chen, Jun Li, Guoning Liao, Yunping Lu, Ding Ma.   

Abstract

The relationship of connexin43 (Cx43) and bystander effect in ovarian tumor cells in herpes simplex virus thymidine kinase/ganciclovir (HSV-TK/GCV) gene therapy in vitro was explored and the effect of all-trans retinoic acid (RA) on the expression of Cx43 and bystander effect investigated. The Cx43 expression was detected by flowcytometry, Western blot, and immunofluorescence in two ovarian tumor cell lines OVCAR3, CaOV3 before and after RA treatment. Bystander effect was determined by the cells growth inhibitory rate with methyl thiazolyl tetrazolium. Following exposure to ganciclovir, there was much greater bystander killing in OVCAR3 than that in CaOV3 (P<0.05). The expression of Cx43 was detected in OVCAR3 by flowcytometry and Western blot, but it could not be detected in CaOV3. The expression of Cx43 in both cell lines could be induced by RA. Immunofluoresence staining showed that Cx43 protein of OVCAR3 was located on membrane surface, whereas CaOV3 in cytoplasm. RA could not change the location of Cx43 protein in both cell lines. There is relationship between Cx43 expression and HSV-TK/GCV bystander effect. HSV-TK/GCV bystander effect can be enhanced by RA in ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15641697     DOI: 10.1007/BF02831113

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  12 in total

1.  Gap junctional intercellular communication and connexin43 expression in human ovarian surface epithelial cells and ovarian carcinomas in vivo and in vitro.

Authors:  E A Hanna; S Umhauer; S L Roshong; M P Piechocki; M J Fernstrom; J D Fanning; R J Ruch
Journal:  Carcinogenesis       Date:  1999-07       Impact factor: 4.944

2.  Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

Authors:  T W Trask; R P Trask; E Aguilar-Cordova; H D Shine; P R Wyde; J C Goodman; W J Hamilton; A Rojas-Martinez; S H Chen; S L Woo; R G Grossman
Journal:  Mol Ther       Date:  2000-02       Impact factor: 11.454

3.  Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer.

Authors:  M Chhikara; H Huang; M T Vlachaki; X Zhu; B Teh; K J Chiu; S Woo; B Berner; E O Smith; K C Oberg; L K Aguilar; T C Thompson; E B Butler; E Aguilar-Cordova
Journal:  Mol Ther       Date:  2001-04       Impact factor: 11.454

4.  Differential effects of TPA and retinoic acid on cell-cell communication in human bronchial epithelial cells.

Authors:  Craig D Albright; Philip M Grimley; Raymond T Jones; James H Resau
Journal:  Exp Mol Pathol       Date:  2002-02       Impact factor: 3.362

5.  Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer.

Authors:  C T Freund; M A Sutton; T Dang; C F Contant; D Rowley; S P Lerner
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

6.  The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro.

Authors:  J Fick; F G Barker; P Dazin; E M Westphale; E C Beyer; M A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.

Authors:  D Barba; J Hardin; M Sadelain; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors.

Authors:  F L Moolten; J M Wells
Journal:  J Natl Cancer Inst       Date:  1990-02-21       Impact factor: 13.506

9.  The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

Authors:  S M Freeman; C N Abboud; K A Whartenby; C H Packman; D S Koeplin; F L Moolten; G N Abraham
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

10.  The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats.

Authors:  Z Ram; S Walbridge; T Shawker; K W Culver; R M Blaese; E H Oldfield
Journal:  J Neurosurg       Date:  1994-08       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.